Wendy Mayer is Vice President, Strategy and New Business Innovative Pharma for Pfizer. Mayer joined Pfizer in 1997, and has had various roles across the commercial organization. Prior to her current role she was Connecticut State Director within Primary Care, responsible for approximately $200 million in revenue. Prior to that she developed a Quality Management System blueprint to embed quality by design principles into Pfizer’s enterprise-wide clinical trial process. Most of her tenure at Pfizer has been within the Market Analytics organization, utilizing primary and secondary market research to develop insights and guide global business strategy.